Prolactin Ovine Antagonist

The production of Prolactin Ovine Antagonist Recombinant involves the insertion of the ovine prolactin gene into E. coli bacteria, which then express the protein. The protein is subsequently purified using proprietary chromatographic techniques to ensure high purity and biological activity .

Prolactin Ovine Antagonist Recombinant is designed to act as an antagonist to prolactin, meaning it binds to prolactin receptors but does not activate them. This can be useful in research and therapeutic contexts where inhibition of prolactin activity is desired. The antagonist form of prolactin can help in studying the hormone’s role in various physiological processes and in developing treatments for conditions where prolactin’s activity needs to be modulated .

The recombinant form of prolactin, including its antagonist, is widely used in laboratory research to study prolactin’s effects on cell proliferation, differentiation, and other cellular processes. It is also used in the development of therapeutic strategies for conditions such as prolactinomas (prolactin-secreting tumors), breast cancer, and other disorders related to prolactin dysregulation .

Lyophilized (freeze-dried) Prolactin Ovine Antagonist Recombinant is stable at room temperature for up to three weeks, but for long-term storage, it should be kept desiccated below -18°C. Upon reconstitution, it should be stored at 4°C for short-term use (2-7 days) and below -18°C for long-term use. It is recommended to add a carrier protein (such as 0.1% HSA or BSA) to prevent freeze-thaw cycles .